You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 8, April 28, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Adverse Effects
 •Alert me on articles by topic

Low-Molecular-Weight Heparin for Anticoagulation During Continuous Venovenous Hemofiltration—Reply

Since this article does not have an abstract, we have provided the first 63 words of the full text and any section headings.

In reply

We would like to thank Dr Knight and colleagues for their interest in our article. We wish to point out that the results they describe do not apply to the population that we investigated. Data derived from patients undergoing dialysis were excluded from our report.

Jeff Nagge, BScPhm, BSc
Toronto, Ontario

Mark Crowther, MD, MSc; Jack Hirsh, MD, FCCP
Hamilton, Ontario

Arch Intern Med. 2003;163:981.


RELATED ARTICLE

Low-Molecular-Weight Heparin for Anticoagulation During Continuous Venovenous Hemofiltration
David J. W. Knight, David Selwyn, and Keith Girling
Arch Intern Med. 2003;163(8):981.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.